A Prospective Trial of Aggressive Hydration Strategy to Reduce Post-ERCP Pancreatitis

NACompletedINTERVENTIONAL
Enrollment

510

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

June 30, 2016

Conditions
Post-ERCP Acute Pancreatitis
Interventions
DRUG

lactated Ringer's solution (vigorous hydration arm)

"* Initial bolus of lactated Ringer's solution at 10mL/kg over 1 hour prior to ERCP~* Intravenous lactated Ringer's solution at a rate of 3mL/kg/h during the procedure and continued for 8 hours.~* At the end of ERCP, post-procedure bolus of lactated Ringer's solution at 10mL/Kg over 1hour"

DRUG

lactated Ringer's solution (standard hydration arm)

\- Patients will receive lactated Ringer's solution at the start of the ERCP and the fluids will be administered at a rate of 1.5ml/kg/h during the procedure and for 8hours after ERCP.

DEVICE

endoscopic retrograde cholangiopancreatography (ERCP)

endoscopic retrograde cholangiopancreatography

Trial Locations (3)

330-715

Dankook University College of Medicine, Cheonan

Unknown

Wonkwang University, Iksan

University of Ulsan, Ulsa University Hospital, Ulsan

All Listed Sponsors
collaborator

Wonkwang University

OTHER

collaborator

University of Ulsan

OTHER

lead

Dankook University

OTHER

NCT02308891 - A Prospective Trial of Aggressive Hydration Strategy to Reduce Post-ERCP Pancreatitis | Biotech Hunter | Biotech Hunter